Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

10.87
Delayed Data
As of Aug 28
 +0.04 / +0.37%
Today’s Change
9.16
Today|||52-Week Range
17.53
-29.87%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close10.83
Today’s open10.65
Day’s range10.64 - 11.00
Volume1,258,758
Average volume (3 months)1,688,887
Market cap$1.4B
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-40.48%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio232.2
Price/Sales9.80
Price/Book39.26

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.74+3.10%
EXELExelixis Inc-0.04-0.66%
LXRXLexicon Pharmaceutic...+0.56+4.62%
NXTMNxStage Medical Inc-0.37-2.09%
Data as of 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers